Catalyst Wire Dossier Catalyst Wire Dossier

GSK2336805

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for GSK2336805, covering 2014-06-17 to 2017-12-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects [Phase 2]

See pricing